Latest revenue
$1.04B
as of 2026-03-31
Latest net income
$58.3M
as of 2026-03-31
Net margin
5.6%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $7.59B
- Enterprise value
- $7.59B
- P/E (trailing)
- 37.6×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $171.58
- 52-wk low
- $56.10
- Beta
- —
- Shares out
- 51.0M
5-year trend
What this company does
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. The following information should be read in conjunction with the unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q (“Quarterly Report”). The following discussion may contain forward-looking statements that are based upon current expectations and are subject to uncertainty and changes in circumstances. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those factors discussed in the following and…
AI summary unavailable — showing raw filing excerpt
Generated from ECG's filing dated 2026-05-06
Key risks
Item 1A. Risk Factors. As of March 31, 2026, there were no material changes to the Company's risk factors that were previously disclosed in the Company’s 2025 Annual Report. Please refer to the Company's 2025 Annual Report for the risk factors that could materially harm the Company's business, prospects, financial results and/or financial condition if they occur.
AI summary unavailable — showing raw filing excerpt
Generated from ECG's filing dated 2026-05-06
Profitability
Gross margin
12.1%
1.8%Operating margin
7.1%
6.0%Net margin
5.4%
7.0%Return on equity
32.0%
0.3%Return on assets
11.7%
4.9%Leverage
Debt / equity
1.74×
6.7%Long-term debt / equity
0.42×
32.3%Debt / assets
63.6%
2.4%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $1.04B | +25.4% | $58.3M | +59.0% | 5.6% |
Q4 2025 2025-12-31 | $1.01B | +33.2% | $55.3M | +60.4% | 5.5% |
Q3 2025 2025-09-30 | $986.8M | +29.7% | $57.0M | +36.4% | 5.8% |
Q2 2025 2025-06-30 | $921.5M | +31.0% | $52.8M | +35.6% | 5.7% |
Q1 2025 2025-03-31 | $826.6M | +32.1% | $36.7M | +30.0% | 4.4% |
Q4 2024 2024-12-31 | $759.6M | — | $34.5M | — | 4.5% |
Q3 2024 2024-09-30 | $761.0M | +6.1% | $41.8M | +16.0% | 5.5% |
Q2 2024 2024-06-30 | $703.4M | — | $39.0M | — | 5.5% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Operative Builders · SIC 1531
Your notes
Keep private notes on ECG — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$23.0K
Insider selling
$0
Net activity
+$23.0K
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ECG
Institutional value
$2.99B
Total shares held
25.9M
Distinct holders
323
-57 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6.1M | $719.1M | -1.9K (-0.0%) | Trimmed |
| 2 | WASATCH ADVISORS LP | 3.0M | $356.2M | +856.9K (+39.7%) | Added |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.6M | $304.8M | — | New |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $270.5M | — | New |
| 5 | FIRST TRUST ADVISORS LP | 1.3M | $151.2M | +670.6K (+109.9%) | Added |
| 6 | Capital International Investors | 1.1M | $131.6M | -821.2K (-42.4%) | Trimmed |
| 7 | DIMENSIONAL FUND ADVISORS LP | 1.1M | $130.4M | +10.8K (+1.0%) | Added |
| 8 | Invesco Ltd. | 956.6K | $112.9M | -276.0K (-22.4%) | Trimmed |
| 9 | Capital World Investors | 614.3K | $72.5M | — | New |
| 10 | De Lisle Partners LLP | 367.4K | $43.4M | +0 (+0.0%) | No change |
| 11 | VANGUARD FIDUCIARY TRUST CO | 317.2K | $37.5M | — | New |
| 12 | Swedbank AB | 300.0K | $35.4M | -420.0K (-58.3%) | Trimmed |
| 13 | Bank of New York Mellon Corp | 275.9K | $32.6M | -4.6K (-1.7%) | Trimmed |
| 14 | UBS Group AG | 271.4K | $32.0M | -236.9K (-46.6%) | Trimmed |
| 15 | TEACHER RETIREMENT SYSTEM OF TEXAS | 265.9K | $31.4M | +142.5K (+115.5%) | Added |
| 16 | abrdn plc | 257.7K | $30.4M | — | New |
| 17 | PRINCIPAL FINANCIAL GROUP INC | 247.2K | $29.2M | +4.8K (+2.0%) | Added |
| 18 | Nuveen, LLC | 195.6K | $23.1M | -3.3K (-1.7%) | Trimmed |
| 19 | Public Sector Pension Investment Board | 182.5K | $21.5M | +6.0K (+3.4%) | Added |
| 20 | SEI INVESTMENTS CO | 181.4K | $21.4M | +38.6K (+27.1%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ECG's latest filing finishes processing.